Инструмент | Доходность к погашению % | Объём | Цена % | Купонная доходность % | Срок погашения | Задолженность | Номинал | Мин. деноминация | Эмитент |
---|---|---|---|---|---|---|---|---|---|
RPHC5824522Royalty Pharma plc 5.9% 02-SEP-2054 | 5,85% | 7,4 M | 100,75% | 5,90% | 2054-09-02 | 500 M USD | 1 000,00 USD | 2 000,00 USD | Royalty Pharma Plc |
RPHC5237891Royalty Pharma plc 3.3% 02-SEP-2040 | 5,61% | 4,352 M | 74,74% | 3,30% | 2040-09-02 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Royalty Pharma Plc |
RPHC5237919Royalty Pharma plc 3.55% 02-SEP-2050 | 5,54% | 1,67 M | 70,08% | 3,55% | 2050-09-02 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Royalty Pharma Plc |
RPHC5222528Royalty Pharma plc 3.35% 02-SEP-2051 | 5,52% | 660 K | 66,52% | 3,35% | 2051-09-02 | 700 M USD | 1 000,00 USD | 2 000,00 USD | Royalty Pharma Plc |
RPHC5824521Royalty Pharma plc 5.4% 02-SEP-2034 | 5,41% | 12,158 M | 99,93% | 5,40% | 2034-09-02 | 500 M USD | 1 000,00 USD | 2 000,00 USD | Royalty Pharma Plc |
RPHC5237916Royalty Pharma plc 2.2% 02-SEP-2030 | 5,05% | 162 K | 85,57% | 2,20% | 2030-09-02 | 996,812 M USD | 1 000,00 USD | 2 000,00 USD | Royalty Pharma Plc |
RPHC5222527Royalty Pharma plc 2.15% 02-SEP-2031 | 5,03% | 601 K | 83,28% | 2,15% | 2031-09-02 | 600 M USD | 1 000,00 USD | 2 000,00 USD | Royalty Pharma Plc |
RPHC5824520Royalty Pharma plc 5.15% 02-SEP-2029 | 5,01% | 79 K | 100,60% | 5,15% | 2029-09-02 | 500 M USD | 1 000,00 USD | 2 000,00 USD | Royalty Pharma Plc |
RPHC5237354Royalty Pharma plc 1.75% 02-SEP-2027 | 4,70% | 160 K | 92,25% | 1,75% | 2027-09-02 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Royalty Pharma Plc |
RPHC5237914Royalty Pharma plc 1.2% 02-SEP-2025 | 4,26% | 12,074 M | 97,01% | 1,20% | 2025-09-02 | 999,962 M USD | 1 000,00 USD | 2 000,00 USD | Royalty Pharma Plc |
RPHC5035520Royalty Pharma plc 2.2% 02-SEP-2030 | 2,44% | 0 | 98,72% | 2,20% | 2030-09-02 | 3,188 M USD | 1 000,00 USD | 2 000,00 USD | Royalty Pharma Plc |
RPHC5035516Royalty Pharma plc 1.2% 02-SEP-2025 | 1,59% | 0 | 99,62% | 1,20% | 2025-09-02 | 38 K USD | 1 000,00 USD | 2 000,00 USD | Royalty Pharma Plc |